Bookmark and Share
neohesperidin dihydrochalcone (CID 30231) - Compound BioActivity Data
.
BioActivity Outcomes:
Inactive(233)
 
 
Inconclusive(12)
 
 
Unspecified(7)
 
 
Top Targets:
NR LBD PPAR(13)
 
 
 
NR LBD ER(9)
 
 
NR LBD AR(9)
 
 
 
NR LBD TR(7)
 
 
NR LBD VDR(6)
 
 
 
BioAssay Types:
Confirmatory(212)
 
 
 
Summary(24)
 
 
Literature(7)
 
 
 
BioActivity Types:
Potency(193)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 241    Data Row: 252   Total Pages: 6   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103759732]
Sensory evaluation was done for sweetness at a concentration of 250 p.p.m. against sample intensity relative to 10% sucrose. [AID89764, Type: Literature]
View
2
[SID103759732]
Sensory evaluation was done for sweetness at a concentration of 250 p.p.m. against compound potency calculated on a molar basis . [AID90088, Type: Literature]
View
3
[SID103759732]
Sensory evaluation was done for sweetness at a concentration of 250 p.p.m. against compound potency calculated on weight basis. [AID90226, Type: Literature]
View
4
[SID103759732]
Sensory evaluation was done at a concentration of 250 p.p.m. against other properties. [AID90264, Type: Literature]
View
5
[SID103759732]
Sensory evaluation was done at a concentration of 250 p.p.m. against property of bitterness. [AID90265, Type: Literature]
View
6
[SID103759732]
Sensory evaluation was done at a concentration of 250 p.p.m. against property of sweetness. [AID90266, Type: Literature]
View
7
[SID17388867]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
8
[SID17388867]
Potency Cell Viability - LYMP1-002 - Assay at 40 hr [AID994, Type: confirmatory]
View
9
[SID17388867]
Potency qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia [AID1477, Type: confirmatory]
View
10
[SID17388867]
Potency qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory]
View
11
[SID17388867]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay [AID651754, Type: confirmatory]
View
12
[SID17388867]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory]
View
13
[SID17388867]
Potency qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory]Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097]
View
14
[SID17388867]
Potency qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory]Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581]
View
15
[SID144207501]
Potency-Replicate_1 qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 [AID651632, Type: confirmatory]ATPase family AAA domain-containing protein 5 [gi:296439460]
View
16
[SID144207501]
ATAD5 Potency (uM) qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary [AID720516, Type: summary]ATPase family AAA domain-containing protein 5 [gi:296439460]
View
17
[SID17388867]
Potency qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory]glucocorticoid receptor [Homo sapiens] [gi:311348376]
View
18
[SID17388867]
Potency qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory]glucocorticoid receptor [Homo sapiens] [gi:311348376]
View
19
[SID144207501]
Potency-Replicate_1 qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway [AID720691, Type: confirmatory]glucocorticoid receptor [Homo sapiens] [gi:311348376]
View
20
[SID144207501]
Ratio Potency (uM) qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary [AID743241, Type: summary]vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708]
View
21
[SID144207501]
qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary [AID743242, Type: summary]vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708]
View
22
[SID17388867]
Potency qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
23
[SID144207501]
Potency-Replicate_1 qHTS assay for small molecule agonists of the p53 signaling pathway [AID651631, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
24
[SID144207501]
Ratio Potency (uM) qHTS assay for small molecule agonists of the p53 signaling pathway: Summary [AID720552, Type: summary]Cellular tumor antigen p53 [gi:269849759]
View
25
[SID144207501]
Potency-Replicate_1 qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen [AID743209, Type: confirmatory]
View
26
[SID144207501]
Potency-Replicate_1 qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen [AID743211, Type: confirmatory]
View
27
[SID144207501]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen [AID743213, Type: confirmatory]
View
28
[SID144207501]
Potency-Replicate_1 qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen [AID743218, Type: confirmatory]
View
29
[SID144207501]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen [AID743221, Type: confirmatory]
View
30
[SID17388867]
Potency Cell Viability - LYMP2-018 [AID985, Type: confirmatory]
View
31
[SID17388867]
Potency Cell Viability - LYMP2-020 [AID986, Type: confirmatory]
View
32
[SID17388867]
Potency Cell Viability - LYMP2-022 [AID987, Type: confirmatory]
View
33
[SID17388867]
Potency Cell Viability - LYMP2-024 [AID988, Type: confirmatory]
View
34
[SID17388867]
Potency Cell Viability - LYMP2-026 [AID989, Type: confirmatory]
View
35
[SID17388867]
Potency Cell Viability - LYMP1-002 - Assay at 24 hr [AID993, Type: confirmatory]
View
36
[SID17388867]
Potency Cell Viability - LYMP2-007 [AID979, Type: confirmatory]
View
37
[SID17388867]
Potency Cell Viability - LYMP2-008 [AID980, Type: confirmatory]
View
38
[SID17388867]
Potency Cell Viability - LYMP2-010 [AID981, Type: confirmatory]
View
39
[SID17388867]
Potency Cell Viability - LYMP2-012 [AID982, Type: confirmatory]
View
40
[SID17388867]
Potency Cell Viability - LYMP2-014 [AID983, Type: confirmatory]
View
41
[SID17388867]
Potency Cell Viability - LYMP2-016 [AID984, Type: confirmatory]
View
42
[SID17388867]
Potency Cell Viability - LYMP2-019 [AID973, Type: confirmatory]
View
43
[SID17388867]
Potency Cell Viability - LYMP2-021 [AID974, Type: confirmatory]
View
44
[SID17388867]
Potency Cell Viability - LYMP2-023 [AID975, Type: confirmatory]
View
45
[SID17388867]
Potency Cell Viability - LYMP2-025 [AID976, Type: confirmatory]
View
46
[SID17388867]
Potency Cell Viability - LYMP2-002 [AID977, Type: confirmatory]
View
47
[SID17388867]
Potency Cell Viability - LYMP2-006 [AID978, Type: confirmatory]
View
48
[SID17388867]
Potency Cell Viability - LYMP2-005 [AID967, Type: confirmatory]
View
49
[SID17388867]
Potency Cell Viability - LYMP2-009 [AID968, Type: confirmatory]
View
50
[SID17388867]
Potency Cell Viability - LYMP2-011 [AID969, Type: confirmatory]
View